Johnathan E. Lawrence
Northern Michigan University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Johnathan E. Lawrence.
Neurology Research International | 2012
Johnathan E. Lawrence; Nicholas J Cook; Richard A. Rovin; Robert J. Winn
The hormone leptin has a variety of functions. Originally known for its role in satiety and weight loss, leptin more recently has been shown to augment tumor growth in a variety of cancers. Within gliomas, there is a correlation between tumor grade and tumor expression of leptin and its receptor. This suggests that autocrine signaling within the tumor microenvironment may promote the growth of high-grade gliomas. Leptin does this through stimulation of cellular pathways that are also advantageous for tumor growth and recurrence: antiapoptosis, proliferation, angiogenesis, and migration. Conversely, a loss of leptin expression attenuates tumor growth. In animal models of colon cancer and melanoma, a decline in the expression and secretion of leptin resulted in a reduction of tumor growth. In these models, positive mental stimulation through environmental enrichment decreased leptin secretion and improved tumor outcome. This review explores the link between leptin and glioblastoma.
International Scholarly Research Notices | 2014
Johnathan E. Lawrence; Ashish S. Patel; Richard A. Rovin; Robert J. Belton; Catherine E. Bammert; Christopher J. Steele; Robert J. Winn
Introduction. 5-Aminolevulinic Acid (5-ALA) is a precursor of heme synthesis. A metabolite, protoporphyrin IX (PpIX), selectively accumulates in neoplastic tissue including glioblastoma. Presurgical administration of 5-ALA forms the basis of fluorescence-guided resection (FGR) of glioblastoma (GBM) tumors. However, not all gliomas accumulate sufficient quantities of PpIX to fluoresce, thus limiting the utility of FGR. We therefore developed an assay to determine cellular and pharmacological factors that impact PpIX fluorescence in GBM. This assay takes advantage of a GBM cell line engineered to express yellow fluorescent protein. Methods. The human GBM cell line U87MG was transfected with a YFP expression vector. After treatment with a series of 5-ALA doses, both PpIX and YFP fluorescence were measured. The ratio of PpIX to YFP fluorescence was calculated. Results. YFP fluorescence permitted the quantification of cell numbers and did not interfere with 5-ALA metabolism. The PpIX/YFP fluorescence ratio provided accurate relative PpIX levels, allowing for the assessment of PpIX accumulation in tissue. Conclusion. Constitutive YFP expression strongly correlates with cell number and permits PpIX quantification. Absolute PpIX fluorescence alone does not provide information regarding PpIX accumulation within the cells. Our research indicates that our PpIX/YFP ratio assay may be a promising model for in vitro 5-ALA testing and its interactions with other compounds during FGR surgery.
Neurosurgery | 2012
Keith Z Sabin; Richard A. Rovin; Johnathan E. Lawrence; Robert J. Belton; Robert J. Winn
Introduction Glioblastoma multiforme deploys a number of weapons to thwart the immune system. Within the tumor microenvironment, tumor infiltrating T cells fall victim to cellular and soluble mediators of apoptosis. In prostate and colorectal cancer models, exosomes can induce T cell apoptosis. Exosomes are tiny, membrane bound vesicles that are released from a cell. They contain functional mRNA and protein and have cell surface molecules representative of their parent cell. It is not known if GBM derived exosomes can also mediate apoptosis. In this study, the role of GBM derived exosomes in T cell apoptosis is explored.
Journal of Neuro-oncology | 2016
Johnathan E. Lawrence; Christopher J. Steele; Richard A. Rovin; Robert J. Belton; Robert J. Winn
ISBS - Conference Proceedings Archive | 2005
Randall L. Jensen; Philipp B. Watts; Johnathan E. Lawrence; Jacob M. Wagonsomer
Archive | 2015
Johnathan E. Lawrence; Cathy E. Bammert; Robert J. Belton; Richard A. Rovin; Robert J. Winn
Neuro-oncology | 2011
Keith Z Sabin; Danny Lebert; Vanessa Thibado; Richard A. Rovin; Johnathan E. Lawrence; Robert J. Winn
Neuro-oncology | 2017
Edward Raack; Matthew Jennings; Robert J. Belton; Johnathan E. Lawrence; Christopher McMahon; Robert J. Winn; Paul Mann
Neuro-oncology | 2013
Christopher J. Steele; Johnathan E. Lawrence; Richard A. Rovin; Robert J. Winn
Neuro-oncology | 2012
Johnathan E. Lawrence; Nicholas J Cook; Richard A. Rovin; Robert J. Belton; Robert J. Winn